Stock SNBOY SANBIO COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Calendar SanBio Company Limited OTC Markets

Equities

SNBOY

US7995731004

Market Closed - OTC Markets
Other stock markets
 19:09:17 09/04/2024 BST 		5-day change 1st Jan Change
2.81 USD -48.72% Intraday chart for SanBio Company Limited -.--% -.--%
03-19 SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March MT
03-19 Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform MT

Chart calendar SanBio Company Limited

639600ce077fc77186.sX3Ckrdg5JEit3h0G_QoOxSLxtYEulHsxHjvRHNtFWE.gze71-EOgPMRgx9FTLJNCUfKiLBH42Spp0y3BgdYQlPDFrSn_BKgpWCPGw~fc0ec2bce557508b65d3d60fd11d0d12

Upcoming events on SanBio Company Limited

12/06/2024 Q1 2024 Earnings Release
11/09/2024 Q2 2024 Earnings Release (Projected)
11/12/2024 Q3 2024 Earnings Release (Projected)
12/03/2025 Q4 2024 Earnings Release (Projected)
12/06/2025 Q1 2025 Earnings Release (Projected)

Past events on SanBio Company Limited

18/03/2024 Q4 2023 Earnings Call
17/03/2024 Q4 2023 Earnings Release
13/12/2023 Q3 2023 Earnings Release
13/09/2023 Q2 2023 Earnings Release
13/06/2023 Q1 2023 Earnings Release
25/04/2023 Annual General Meeting
15/03/2023 Q4 2022 Earnings Release
14/12/2022 Q3 2023 Earnings Release
13/06/2022 Q1 2022 Earnings Release
05/04/2022 17:15 American Academy of Neurology Meeting
10/03/2022 FY 2021 Earnings Call
10/03/2022 FY 2021 Earnings Release
14/12/2021 Q3 2021 Earnings Release
13/09/2021 Interim 2021 Earnings Release
13/06/2021 Q1 2021 Earnings Release
16/03/2021 FY 2020 Earnings Release
14/12/2020 Q3 2020 Earnings Release
13/09/2020 Interim 2020 Earnings Release
11/06/2020 Q1 2020 Earnings Release
27/04/2020 Annual General Meeting

Annual results

Fiscal PeriodJanuary 2020 2021 2022 2023 2024 2025
Net sales
Million JPY		Released
Forecast
Spread 		447
444
0.68%		0,00
403
- 		0,00
0,00
- 		0,00
219
- 		0,00
0,00
-
0,00

EBITDA
Million JPY		Released
Forecast
Spread 		-5 446
-4 831
-12.74%		-5 727
-5 911
3.11%		-6 488
-6 332
-2.47%		-7 875
-7 851
-0.3%		-4 525
-4 480
-1.02%
-3 106

EBIT
Million JPY		Released
Forecast
Spread 		-5 486
-5 083
-7.94%		-5 802
-6 023
3.67%		-6 620
-6 589
-0.47%		-7 899
-7 444
-6.12%		-4 540
-5 176
12.3%
-4 040

Earnings before Tax (EBT)
Million JPY		Released
Forecast
Spread 		-5 157
-4 605
-11.98%		-3 211
-6 669
51.84%		-4 560
-4 515
-1%		-4 697
-4 046
-16.09%		-2 542
-3 731
31.87%
-3 532

Net income
Million JPY		Released
Forecast
Spread 		-5 158
-4 607
-11.96%		-3 386
-6 133
44.8%		-4 677
-4 617
-1.3%		-5 559
-5 076
-9.52%		-2 644
-4 079
35.16%
-3 295

EPS
JPY		Released
Forecast
Spread 		-101
-90,7
-11.27%		-65,4
-119
44.92%		-90,3
-89,2
-1.31%		-96,0
-89,1
-7.76%		-40,5
-63,1
35.89%
-49,1

Announcement Date16/03/2017/03/2111/03/2216/03/2318/03/24-

Quarterly results

Fiscal PeriodJanuary 2020 S2 2021 S1 2021 S2 2022 S1 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4
Net sales
Million JPY		Released
Forecast
Spread 		19,5
22,0
-11.55%


0,00
0,00
-


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
875
- 		0,00
174
- 		0,00
349
- 		0,00
523
- 		0,00
523
-
698

EBIT
Million JPY		Released
Forecast
Spread 		-3 101
-2 715
-14.21%		-2 570


-3 232
-3 129
-3.28%		-3 052


-1 844
-1 400
-31.71%		-2 778
-1 317
-110.93%		-4 622
-3 161
-46.22%		-1 783
-1 427
-24.95%		-1 494
-530
-181.9%		-1 461
-1 746
16.32%		-1 623
-1 104
-47.02%		-3 085
-2 850
-8.24%		-640
-1 092
41.36%		-814
-703
-15.75%
Earnings before Tax (EBT)
Million JPY		Released
Forecast
Spread 		-3 109
-2 553
-21.79%		-3 205


-6,00
-2 593
99.77%		-2 127


869





-774


1 211





-866





-1 858


116





Net income
Million JPY		Released
Forecast
Spread 		-3 109
-2 551
-21.87%		-3 207


-179
-2 593
93.1%		-2 134


-315





-2 154


396





-626





-1 787


-96,0





EPS
JPY		Released
Forecast
Spread


-61,9





-41,2


-5,98





-39,3


8,14





-9,68





-27,6


-1,40





Announcement Date16/03/2014/09/2017/03/2114/09/2114/06/2214/09/2214/09/2215/12/2216/03/2314/06/2314/09/2314/09/2314/12/2318/03/24

Upcoming sector events for SanBio Company Limited

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for SanBio Company Limited

17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 13:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 13:00 IMMUNOME, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4592 Stock
  4. SNBOY Stock
  5. Calendar SanBio Company Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW